Full text is available at the source.
Abstract
This cohort study evaluates early treatment trends of oral semaglutide among adults eligible for obesity management medications.
- Oral semaglutide was evaluated for its use in managing obesity in adults.
- The study focused on treatment patterns following the medication's approval.
- Data may reveal insights into how quickly patients adopt this new obesity treatment.
Simplified
GLP-1 Therapies